Literature DB >> 2107627

Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x).

K Ornvold1, E Ralfkiaer, H Carstensen.   

Abstract

The immunophenotypic properties of the abnormal cells in routine specimens from 16 cases of Langerhans cell histiocytosis (LCH) were examined. In five cases, cryostat sections were also available. The abnormal cells expressed a similar phenotype and were positive for HLA-DR, S-100 protein, peanut agglutinin (PNA), CD1a, CD4 and several macrophage-associated markers, including CD11c, CDw32 and CD68 (the latter detectable in routine sections with antibody KP1). Staining with CD14, CD35 (C3b receptor), and CD11b (C3bi receptor) was negative with the exception of one of the cases in which a proportion of the cells showed faint positivity with CD11b. Staining for pan-T-cell (CD2, CD3, CD5) and pan-B-cell (CD19, CD22) antigens was negative in all lesions. It is concluded that LCH expresses a characteristic phenotype with some heterogeneity with regard to macrophage markers and that immunohistochemical methods in cryostat sections and routine specimens form a useful supplement to other techniques for the diagnosis of this condition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107627     DOI: 10.1007/bf01605145

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  23 in total

1.  Histiocytosis x--an analysis of prognostic factors.

Authors:  E Lahey
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

2.  Histiocytic differentiation in benign and malignant bone tumors.

Authors:  A Meyer; T Steinmeier; T Löning; H J Radzun; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Histiocytosis X Langerhans cells react with antiinterleukin-2 receptor monoclonal antibody.

Authors:  S Barbey; P Gane; O Le Pelletier; C Nezelof
Journal:  Pediatr Pathol       Date:  1987

4.  Langerhans cell histiocytosis: an unusual case illustrating the value of immunohistochemistry in diagnosis.

Authors:  P A Hall; C J O'Doherty; D A Levison
Journal:  Histopathology       Date:  1987-11       Impact factor: 5.087

5.  Distribution of cell surface antigens in histiocytosis X cells. Quantitative immunoelectron microscopy using monoclonal antibodies.

Authors:  G F Murphy; T J Harrist; A K Bhan; M C Mihm
Journal:  Lab Invest       Date:  1983-01       Impact factor: 5.662

Review 6.  Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues. I. Range of antibodies and staining patterns.

Authors:  A J Norton; P G Isaacson
Journal:  Histopathology       Date:  1989-05       Impact factor: 5.087

7.  Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.

Authors:  E Ralfkiaer; T A Saati; J Bosq; G Delsol; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

8.  Diagnosis of acute myeloid leukaemia with the use of monoclonal anti-neutrophil elastase (NP57) reactive with routinely processed biopsy samples.

Authors:  E Ralfkiaer; K A Pulford; A F Lauritzen; S Avnstrøm; B Guldhammer; D Y Mason
Journal:  Histopathology       Date:  1989-06       Impact factor: 5.087

9.  Peanut agglutinin. A useful marker for histiocytosis X and interdigitating reticulum cells.

Authors:  H J Ree; M E Kadin
Journal:  Cancer       Date:  1986-01-15       Impact factor: 6.860

10.  Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.

Authors:  R A Warnke; K A Pulford; G Pallesen; E Ralfkiaer; D C Brown; K C Gatter; D Y Mason
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

View more
  6 in total

1.  Differential Expression of Markers in Extensive and Restricted Langerhans Cell Histiocytosis (LCH).

Authors:  Ferenc Kôhalmi; János Strausz; Márta Egerváry; György Szekeres; József Tímár
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Authors:  Tricia L Peters; Kenneth L McClain; Carl E Allen
Journal:  Mol Ther       Date:  2011-06-07       Impact factor: 11.454

3.  Expression of the monoclonal antibody HECA-452 defined E-selectin ligands in Langerhans cell histiocytosis.

Authors:  I Simonitsch; C W Kopp; I Mosberger; B Volc-Platzer; T Radaszkiewicz
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

4.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

5.  Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps; W Timens
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

6.  Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II Antigens.

Authors:  Lucas Redd; Monika Schmelz; W Richard Burack; James R Cook; Antony W Day; Lisa Rimsza
Journal:  J Hematop       Date:  2016-03-10       Impact factor: 0.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.